Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Carlos Tutor

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Clinical Laboratory|October 24, 2003
More on the reliability of the microparticle enzyme immunoassay (MEIA) for therapeutic tacrolimus monitoringJesús Hermida, J Carlos Tutor
Therapeutic Drug Monitoring|June 17, 2006
Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycinJesús Hermida, J Carlos Tutor
Clinical Laboratory|April 13, 2004
Effect of analytical inaccuracy on dose adjustment for gentamicin using the Abbottbase Pharmacokinetic SystemsLorena Bouzas, Jesus Hermida, J Carlos Tutor
Scandinavian Journal of Clinical and Laboratory Investigation|January 18, 2012
Determination of everolimus in blood samples from kidney and liver transplant recipients using the sirolimus chemiluminescence magnetic microparticle immunoassay (CMIA) on the Architect-i1000® systemEsperanza F Hermida-Cadahia, J Carlos Tutor
Therapeutic Drug Monitoring|November 27, 2002
Effect of analytical inaccuracy on dose adjustment for vancomycin, amikacin, and tobramycin using the Abbottbase Pharmacokinetic SystemsSofia Zaera, Jesus Hermida, J Carlos Tutor
Upsala Journal of Medical Sciences|November 2, 2010
A limited sampling strategy for estimation of the area under the curve (0 to 8 hours) of mycophenolic acid administered three times daily to liver transplant recipientsBernardino Marcos, Lorena Bouzas, J Carlos Tutor
Upsala Journal of Medical Sciences|February 27, 2009
Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet methodLorena Bouzas, Jesús Hermida, J Carlos Tutor
Upsala Journal of Medical Sciences|December 1, 2009
Sirolimus and everolimus clearance in maintenance kidney and liver transplant recipients: diagnostic efficiency of the concentration/dose ratio for the prediction of trough steady-state concentrationsLorena Bouzas, Jesús Hermida, J Carlos Tutor
Clinical Laboratory|January 8, 2013
Investigation of possible interference by digoxin-like immunoreactive substances on the Architect iDigoxin CMIA in serum samples from pregnant women, and patients with liver disease, renal insufficiency, critical illness, and kidney and liver transplantNatalia Lampon, Fernando Pampin, J Carlos Tutor
Therapeutic Drug Monitoring|January 29, 2008
Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patientsJesús Hermida, Eduardo Paz, J Carlos Tutor
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Clinical Laboratory|October 24, 2003
More on the reliability of the microparticle enzyme immunoassay (MEIA) for therapeutic tacrolimus monitoringJesús Hermida, J Carlos Tutor
Therapeutic Drug Monitoring|June 17, 2006
Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycinJesús Hermida, J Carlos Tutor
Clinical Laboratory|April 13, 2004
Effect of analytical inaccuracy on dose adjustment for gentamicin using the Abbottbase Pharmacokinetic SystemsLorena Bouzas, Jesus Hermida, J Carlos Tutor
Scandinavian Journal of Clinical and Laboratory Investigation|January 18, 2012
Determination of everolimus in blood samples from kidney and liver transplant recipients using the sirolimus chemiluminescence magnetic microparticle immunoassay (CMIA) on the Architect-i1000® systemEsperanza F Hermida-Cadahia, J Carlos Tutor
Therapeutic Drug Monitoring|November 27, 2002
Effect of analytical inaccuracy on dose adjustment for vancomycin, amikacin, and tobramycin using the Abbottbase Pharmacokinetic SystemsSofia Zaera, Jesus Hermida, J Carlos Tutor
Upsala Journal of Medical Sciences|November 2, 2010
A limited sampling strategy for estimation of the area under the curve (0 to 8 hours) of mycophenolic acid administered three times daily to liver transplant recipientsBernardino Marcos, Lorena Bouzas, J Carlos Tutor
Upsala Journal of Medical Sciences|February 27, 2009
Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet methodLorena Bouzas, Jesús Hermida, J Carlos Tutor
Upsala Journal of Medical Sciences|December 1, 2009
Sirolimus and everolimus clearance in maintenance kidney and liver transplant recipients: diagnostic efficiency of the concentration/dose ratio for the prediction of trough steady-state concentrationsLorena Bouzas, Jesús Hermida, J Carlos Tutor
Clinical Laboratory|January 8, 2013
Investigation of possible interference by digoxin-like immunoreactive substances on the Architect iDigoxin CMIA in serum samples from pregnant women, and patients with liver disease, renal insufficiency, critical illness, and kidney and liver transplantNatalia Lampon, Fernando Pampin, J Carlos Tutor
Therapeutic Drug Monitoring|January 29, 2008
Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patientsJesús Hermida, Eduardo Paz, J Carlos Tutor
Pageof 6